Grading their responses on a 5-point scale, where 5 represented the highest level of confidence, Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) members were asked the following questions:
On April 30, 2014, the Centers for Medicare & Medicaid Services (CMS) convened the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) to assess the value of low-dose computed tomography (CT) lung cancer screening in the Medicare population. After a decades-long battle,...
Rita Redberg, MD, MS, Chair
Professor of Medicine
UCSF School of Medicine
Division of Cardiology
University of California,
San Francisco, Medical Center
Art Sedrakyan, MD, PhD, Vice Chair
Associate Professor and Director
Patient Centered Comparative Outcomes Research Program
Weill Cornell Medical...